Company Description
The Beauty Health Company designs, develops, manufactures, markets, and sells aesthetic technologies and products worldwide.
The company’s flagship product includes HydraFacial that enhance the skin to cleanse, extract, and hydrate the skin with proprietary solutions and serums.
Its products also comprise Syndeo, a Delivery System designs to connects providers to the consumer’s preferences to create a more personalized experience; consumables, such as single-use tips, solutions, and serums used to provide a hydrafacial treatment; SkinStylus SteriLock Microsystem, a microneedling device used for the treatment of enhancing appearance of surgical or traumatic hypertrophic scars on the abdomen and facial acne scarring in Fitzpatrick skin types I, II, and III; and Keravive, a treatment for scalp health.
The company was founded in 1997 and is headquartered in Long Beach, California.
Country | United States |
Founded | 1997 |
Industry | Household & Personal Products |
Sector | Consumer Staples |
Employees | 881 |
CEO | Marla Beck |
Contact Details
Address: 2165 Spring Street Long Beach, California 90806 United States | |
Phone | 800 603 4996 |
Website | beautyhealth.com |
Stock Details
Ticker Symbol | SKIN |
Exchange | NASDAQ |
Fiscal Year | January - December |
Reporting Currency | USD |
CIK Code | 0001818093 |
CUSIP Number | 88331L108 |
ISIN Number | US88331L1089 |
Employer ID | 85-1908962 |
SIC Code | 3841 |
Key Executives
Name | Position |
---|---|
Marla Malcolm Beck | President, Chief Executive Officer and Director |
Michael P. Monahan | Chief Financial Officer |
Latest SEC Filings
Date | Type | Title |
---|---|---|
Nov 4, 2024 | SC 13G/A | [Amend] Statement of acquisition of beneficial ownership by individuals |
Oct 15, 2024 | 8-K | Current Report |
Aug 30, 2024 | 8-K | Current Report |
Aug 8, 2024 | 10-Q | Quarterly Report |
Aug 8, 2024 | 8-K | Current Report |
Jun 11, 2024 | 8-K | Current Report |
May 17, 2024 | SC 13G | Statement of acquisition of beneficial ownership by individuals |
May 9, 2024 | 10-Q | Quarterly Report |
May 9, 2024 | 8-K | Current Report |
May 2, 2024 | 8-K/A | [Amend] Current report |